The key role of pulmonologists in ALK+ NSCLC care

Jacques Cadranel (Paris, France)

Source: International Congress 2015 – Thoracic oncology: from fusion genes to treatment
Session: Thoracic oncology: from fusion genes to treatment
Session type: Symposium
Number: 1430
Disease area: Thoracic oncology

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jacques Cadranel (Paris, France). The key role of pulmonologists in ALK+ NSCLC care. International Congress 2015 – Thoracic oncology: from fusion genes to treatment

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The key role of pulmonologists in the NSCLC multidisciplinary team
Source: International Congress 2015 – Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient
Year: 2015


Pulmonologists and lung cancer: pivotal role in multidisciplinary approach
Source: Eur Respir J 2013; 42: 1183-1185
Year: 2013


The role of robotics in the treatment of NSCLC
Source: International Congress 2015 – Robotics in pulmonology and thoracic surgery
Year: 2015



Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patients
Source: ERJ Open Res, 4 (1) 00058-2017; 10.1183/23120541.00058-2017
Year: 2018



The role of surgeon in MPM
Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Year: 2019

NSCLC management
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

NSCLC management
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

NSCLC management
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

NSCLC management
Source: ERS Skills Course 2016
Year: 2016

Survival with in-operable non-small cell lung cancer in U.K district general hospital: Is chemotherapy better than active supportive care?
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010

How novel targeted therapies have changed patient outcomes in ALK+ NSCLC
Source: International Congress 2015 – Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient
Year: 2015


Therapeutic management of ALK+ nonsmall cell lung cancer patients
Source: Eur Respir J 2015; 46: 230-242
Year: 2015



The role of palliative radiotherapy in locally advanced non small cell lung cancer
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007



Expressed wishes and incidence of euthanasia in advanced lung cancer patients},
Source: Eur Respir J 2012; 40: 949-956
Year: 2012



The role of palliative care
Source: Annual Congress 2012 - Supportive and palliative care in the management of the patient with a thoracic malignancy
Year: 2012


Biomarkers for non-small cell lung cancer (NSCLC) treatment: examples and unmet needs, a clinical perspective
Source: International Congress 2014 – From bench to bedside: biomarkers and biobanking for lung cancer in 2014
Year: 2014



SCLC management
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

SCLC management
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

SCLC management
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

The role of the practice nurse in the management of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 328s
Year: 2001